Shanghai Pharmaceuticals Holding Co Ltd banner

Shanghai Pharmaceuticals Holding Co Ltd
F:S1R

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
F:S1R
Watchlist
Price: 1.3 EUR 2.36% Market Closed
Market Cap: €6.2B

Intrinsic Value

The intrinsic value for Shanghai Pharmaceuticals Holding Co Ltd (S1R) under the Base Case is 3.02 EUR. Compared with the current market price of 1.3 EUR, the stock appears Undervalued by 57% .

Based on two methods:

Both DCF and multiples point to undervaluation.

S1R Intrinsic Value
3.02 EUR
Undervaluation 57%
Intrinsic Value
Price €1.3
Bear Case
Base Case
Bull Case
Monitor S1R
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €2.41
Get notified when the price drops into your buy zone
Intrinsic Value €3.02
Margin of Safety 20% €2.41
Current Price €1.3
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about S1R?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is S1R valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shanghai Pharmaceuticals Holding Co Ltd.

Explain Valuation
Alternatives to S1R

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one S1R stock?

The intrinsic value for Shanghai Pharmaceuticals Holding Co Ltd (S1R) under the Base Case is 3.02 EUR.

Is S1R stock undervalued or overvalued?

Compared with the current market price of 1.3 EUR, the stock appears Undervalued by 57% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett